Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Qualisys Strenghtens Executive Team with CMO Appointment

Qualisys

As part of its strategic growth agenda, Qualisys has established a new role within the executive leadership team and appoints Susanne Gerdin as Chief Marketing Officer, effective August 2025.

In this newly created role, Susanne will be responsible for leading the company’s global marketing strategy with a strong focus on brand development, market positioning, and customer engagement. As a member of the executive leadership team, she will align marketing initiatives with long-term business goals, support growth across key markets, and strengthen Qualisys’ global presence.

Susanne brings extensive experience from similar roles in international publicly listed companies. Most recently, she served as Marketing Director at LumenRadio, a fast-growing technology company, where she successfully led the marketing function and played a key role in the company’s stock market introduction. Earlier in her career, she held comparable positions in larger corporations, including Gunnebo AB.

“I’m truly excited to join the fantastic team at Qualisys and to contribute to the company’s continued development and strong market position,” says Susanne Gerdin.

“We are very pleased to welcome Susanne to Qualisys. Her proven ability to support growth through strategic marketing will be a valuable asset as we continue to scale,” says Ingemar Pettersson, CEO of Qualisys.

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore and Shanghai. Qualisys is certified according to ISO 9001:2015, the clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

Attachments
Qualisys Strenghtens Executive Team with CMO Appointment

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.